Monday, Sep 28, 2026

"central-drug-authority"

Dr Reddy’s Lab gets nod to carry out bioequivalence study of semaglutide injection

The pharma firm had approached the Drugs Controller General of India (DCGI)seeking a waiver for the phase-III clinical trial of the drug and its market authorisation.

Latest News

BRS leaders protest outside ED office, seek details of Minister Ponguleti case

27 seconds ago
Asian Games 2026: Rain washes out India vs Afghanistan quarterfinal, India advances to semis

7 minutes ago
Chakma council to implement NEP from 2027-28, introduce ‘Mizo Speaking Day’ in schools

30 minutes ago
Mancherial: Two women killed, four injured as lorry rams auto-rickshaw

33 minutes ago
SS Rajamouli reveals quality he admires most in son SS Karthikeya

40 minutes ago
11.12 lakh ration cards in Bengal deactivated since April

41 minutes ago
About 15,000 pilgrims stranded along Kedarnath trek route after landslide evacuated

52 minutes ago
SC takes suo motu cognisance of gang-rape of minor in moving bus in Delhi-NCR

52 minutes ago